← Back to Search

Procedure

Post COVID patient diagnosed with sleep apnea with AHI > 5 for Coronavirus (BreathePA Trial)

N/A

Recruiting

Led By Venkatesh Krishnamurthy, MD

Research Sponsored by Venkatesh Krishnamurthy

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients more than 18 years of age.

Diagnosed with COVID-19 and continues to have persistent symptoms beyond 4 weeks.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4-6 weeks

Awards & highlights

BreathePA Trial Summary

This trial looks at how treating sleep apnea can help reduce brain fog in people who had COVID-19.

Who is the study for?

This trial is for adults over 18 who have had COVID-19 with lingering symptoms past 4 weeks and are diagnosed with sleep apnea. They must have confirmed sleep apnea through a home study.Check my eligibility

What is being tested?

The study observes if using CPAP (a machine that helps people breathe easier while they sleep) can improve 'brain fog' in patients who had COVID-19 and suffer from sleep apnea.See study design

What are the potential side effects?

CPAP side effects may include discomfort, nasal congestion, dry mouth, skin irritation, headaches, and sometimes stomach bloating.

BreathePA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

Select...

I have had COVID-19 symptoms for more than 4 weeks.

BreathePA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4-6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4-6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4-6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline in Montreal Cognitive Assessment at 4-6 Weeks

Secondary outcome measures

Change from Baseline Categorical fluency at 4-6 Weeks

Change from Baseline Digit span backwards and sequential in at 4-6 Weeks

Change from Baseline Multilingual naming test (MINT) test at 4-6 Weeks

+6 more

Side effects data

From 2020 Phase 4 trial • 74 Patients • NCT01807897

16%

Increased dyspnea

Excessive sleepiness

Heart failure

Fall

Stroke

Bronchitis

Pneumonia

Toothache

Skin infection

100%

80%

60%

40%

20%

Study treatment Arm

CPAP

Oxygen

HLSE

BreathePA Trial Design

1Treatment groups

Experimental Treatment

Group I: Post COVID patient diagnosed with sleep apnea with AHI > 5Experimental Treatment1 Intervention

Patients with post COVID syndrome diagnosed with sleep apnea starting CPAP

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Continuous positive airway pressure

2016

Completed Phase 4

~1710

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Breathe PennsylvaniaUNKNOWN

Venkatesh KrishnamurthyLead Sponsor

University of PittsburghLead Sponsor

1,723 Previous Clinical Trials

16,342,926 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research encompass elderly participants?

"This trial seeks participants aged 18 and over, but below the age of 75."

Answered by AI

Do I satisfy the prerequisites for entering this clinical experiment?

"The prerequisites for eligibility in this medical trial entail a diagnosis of sleep apnea and an age between 18 to 75 years old. In total, 30 participants are being sought out."

Answered by AI

Is this research endeavor presently recruiting participants?

"Based on the information listed on clinicaltrials.gov, this trial is no longer seeking participants. It was initially posted on December 1st of 2023 and underwent its last edit seven days later. Fortunately, there are 890 other medical trials recruiting volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea

Venkatesh Krishnamurthy 2024. "CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06052514.

All > Covid 19